Capabilities

Product depth built for how pharma teams actually decide.

From molecule intelligence and risk scoring to NPV/eNPV, materials readiness, and audit-ready governance, every capability stays connected to the same asset record.

Request a workflow-mapped demoSee the platform

Where PortiVix leads

Five capabilities generic tools were not built for.

  • 01

    Molecule Intelligence

    A governed asset record from public FDA data import through enrichment, phase gates, and snapshots.

  • 02

    Risk Intelligence

    PTRS, Business, IP, API/Supply, and KSM scoring separated from delivery risk and issues.

  • 03

    NPV / eNPV

    Risk-adjusted value connected to probability, assumptions, and actuals.

  • 04

    Audit-ready governance

    Traceability created as work happens, actor identity, change history, checksum, export.

  • 05

    Pharma project execution

    Milestone → task → subtask, dependencies, critical path, risks, and issues.

Molecule intelligence

Build and manage every asset record from one governed source of truth.

Create molecules manually or use the Portfolio Builder to start from public FDA datasets, then enrich each asset with commercial assumptions, phase gates, patent fields, risks, financials, materials, documents, and snapshots.

Portfolio Builder

Portfolio Builder

Drug search across public FDA data and Orange Book-style workflows to start a molecule record.

Raw source payload stored for imported records

Manual enrichment after creation

Public data gives a starting point; your teams validate and enrich

Shown: Molecule record, header

Portfolio governance

Leadership visibility without a briefing-pack dependency.

Live visibility into molecule status, project progress, phase movement, risks, issues, resources, and financial signals across the pipeline.

PMO Governance Dashboard in PortiVix: task completion, overdue tasks, milestones, risk heatmap and issue ageing
  • Portfolio Command Centre
  • Portfolio Trends
  • Programme-level PMO Governance Dashboard
  • Portfolio and project Gantt views
  • Access rules by user, role, and discovery mode
  • Named owner accountability

Governed execution

Milestone to activity, with critical path, risks, and issues in one plan.

Structured project plans move pharma teams from informal coordination to accountable execution: Project → Milestone → Task → SubTask, with dependencies, critical path, an interactive Gantt, a project risk register, and an issue tracker.

Abemaciclib project plan in PortiVix with milestones, tasks, owners, dependencies and critical path

Plan structure

  • Milestones, tasks, subtasks, activities
  • Dependencies: FS, SS, FF, SF with lag days
  • Interactive Gantt and critical path indicators
  • Template lock mechanics for governed plans

Risk, issues & sign-off

  • Project risk register: probability, impact, owner, mitigation, residual risk
  • Issue tracker: blockers, deviations, change requests, escalation
  • Task approvals, pending queue, rejection reasons, sign-off
  • Comments, @mentions, documents, activity feed, audit trail

Risk and issue control

Know where risk sits before it becomes a missed milestone or bad capital decision.

PortiVix separates molecule-level decision risk from project-level delivery risk and active issues, giving leadership and PMO teams a clearer view of what could go wrong and what already has.

  • PTRSProbability of technical and regulatory success at phase gates.
  • Business RiskCommercial viability, competition intensity, and strategic fit.
  • IP RiskFreedom-to-operate, patent vulnerability, and patent cliff exposure.
  • API / Supply RiskSupplier concentration, lead time, country risk, and regulatory supply exposure.
  • KSM RiskScoring and commentary.
  • Project Risk RegisterProbability, impact, owner, mitigation, contingency, residual risk, review date, status.
  • Issue TrackerBlockers, deviations, change requests, linked tasks, comments, and escalation.
Abemaciclib risk profile in PortiVix: PTRS 68, Business 74, IP 52, API and supply 61, KSM 80
Risk Control Tower in PortiVix: open risks with severity, heatmap, category and escalation

NPV and eNPV

Connect capital decisions to molecule risk and execution reality.

Each molecule can carry a financial model with NPV and expected NPV, so leaders and finance teams understand value, probability, assumptions, and actuals in the same context as phase gates and risk. Try it: adjust the inputs and watch eNPV move.

NPV (unrisked)
$631m
eNPV (risk-adjusted)
$235m

Phase-gate signal Hold / re-baseline

Illustrative model. In PortiVix, eNPV connects to real assumptions, actuals, PTRS, and risk on each molecule.

Model inputs

  1. 01API priceCOGSannual demandoverheadother costsinvestmentdiscount rateproject durationprobability of successstart year

Outputs & actuals

  1. 01NPV and eNPV for risk-adjusted prioritisation
  2. 02Annual cashflow actuals for comparison against the model
  3. 03What-if recalculation on save

Pharma decision flow

Molecule profile

commercial & patent fields

Shown: Molecule record, header and summary

Materials and supply chain

Bring material readiness into the same view as molecule and project decisions.

For API, formulation, and development teams, material and vendor readiness can decide whether timelines are real.

Materials in PortiVix: exhibit batch readiness with quantities, vendors, lead times and budget
  • DQ, SU, EB (exhibit batch), and Commercial quantity planning
  • Material items: type, CAS number, UOM, contribution %
  • Vendor records: unit price, budget, lead time, country of origin, markets
  • Materials Dashboard for portfolio-level KPIs
  • Version history for traceability

20+ reports and AI-assisted intelligence

Reports built around decisions, not around what happens to be available.

Strategic, monitoring, operational, and compliance reports with saved views, scheduled delivery, exports, and AI-assisted portfolio questions that respect user access permissions.

Strategic

  • Portfolio Command Centre
  • PMO Governance Dashboard
  • Portfolio Trends
  • My Dashboard

Monitoring / Control Tower

  • Risk Control Tower
  • Issue Control Tower
  • Milestone Governance
  • Resource Utilisation

Operational

  • Project Summary
  • Task Completion
  • Workstream Progress
  • Milestone Tracking
  • Project Burndown
  • Employee Utilisation

Data & Compliance

  • Risk Registry
  • Issue Registry
  • Portfolio Health
  • Audit & Compliance

AI Assistant

Ask portfolio questions such as at-risk molecules, top eNPV opportunities, and portfolio health summaries. AI access is scoped by RBAC and audited through tools-used tracking, and it only uses the data available to the authenticated user.

Governance, audit & compliance

Evidence that exists before you need it.

Approval, phase, change, and audit records stay connected to the work as it happens, supporting regulated electronic-record readiness, including 21 CFR Part 11 readiness workflows, subject to customer validation.

Audit trail flow

Action

create · update · export

Event coverage & export

Createupdatedeleteviewexportloginlogout

Permission changes, role assignments, password resets, and more

Shown: Events, Action column

See enterprise controls

See these capabilities mapped to your workflows.

We do not start with a generic demo. We map your portfolio, molecule, project, approval, reporting, and governance workflows first, then show how PortiVix would work for your organisation.

Request a workflow-mapped demo Explore the platform

Or write to marketing@virtunx.com